Primasun debuts ‘efficient, equitable solution’
By HME News Staff
Updated 9:28 AM CST, Mon November 14, 2022
LAS VEGAS – Primasun, a solution to address complex sleep disorders that was formed as a joint venture between ResMed and Verily, launched at the HLTH 2022 event on Nov. 13.
Through its preventative care model, Primasun works with employers and health care providers to identify populations at risk and connects patients to certified sleep physicians who guide them from diagnosis to treatment in a matter of weeks.
"Sleep is the foundation of physical and mental health, and at Primasun, we believe there's an opportunity to build a more efficient, equitable health care solution that helps patients clinically improve their sleep, and in turn, their quality of life," said Jonathon Lobbins, CEO of Primasun. "We're proud to offer a solution that lowers barriers to care, empowers patients to take control of their health, and helps reduce poor sleep's strain on the home, workplace, and healthcare system."
Primasun's initial product offering connects patients with certified sleep physicians who diagnose and treat obstructive sleep apnea, clinically evaluate patients with insomnia symptoms, and provide guidance to improve sleep hygiene.
ResMed announced in 2018 that it was partnering with Verily, an Alphabet precision health company, on a new joint venture to study the health and clinical impacts of undiagnosed and untreated sleep apnea, and to develop software solutions to enable providers to more efficiently diagnose, treat and managing individuals with sleep apnea and other breathing related sleep disorders.
Comments